|4Jan 20, 9:02 AM ET

Flex Pharma, Inc. 4

4 · Flex Pharma, Inc. · Filed Jan 20, 2017

Insider Transaction Report

Form 4
Period: 2017-01-18
Hadfield Robert
General Counsel & Secretary
Transactions
  • Award

    Stock Option (right to buy)

    2017-01-18+57,00057,000 total
    Exercise: $4.58Exp: 2027-01-18Common Stock (57,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest in 48 successive equal monthly installments measured from January 18, 2017.

Documents

1 file
  • 4
    wf-form4_148492096383173.xmlPrimary

    FORM 4